event,time
54 years old ,0.0
    male ,0.0
    presented following motor vehicle collision ,0.0
    Glasgow Coma Scale 13 ,0.0
    Glasgow Coma Scale declined ,0.0
    intubated ,0.0
    admitted to surgical ICU ,0.0
    C1 transverse foramen fracture ,0.0
    bilateral rib fractures ,0.0
    pulmonary contusions ,0.0
    became febrile shortly after admission ,24.0
    lower respiratory culture consistent with polymicrobial pneumonia ,0.0
    started on broad-spectrum antibiotics ,0.0
    family provided history of active crack cocaine use ,48.0
    restarted on quetiapine 400 mg at bedtime ,48.0
    restarted on mirtazapine 30 mg at bedtime ,48.0
    persistent intermittent agitation ,48.0
    agitation difficult to control despite opioids ,48.0
    agitation difficult to control despite dexmedetomidine ,48.0
    agitation difficult to control despite lorazepam ,48.0
    received intravenous haloperidol 5 mg for agitation ,120.0
    febrile to 102.2°F–104.7°F ,144.0
    acetaminophen ,144.0
    cooling blanket ,144.0
    ice saline gastric lavage ,144.0
    developed tachycardia ,144.0
    developed hypertension ,144.0
    diffuse lead-pipe rigidity ,144.0
    hyperreflexia ,144.0
    two-beat clonus ,144.0
    differential diagnosis broadened to include sepsis ,144.0
    differential diagnosis broadened to include NMS ,144.0
    differential diagnosis broadened to include serotonin syndrome ,144.0
    differential diagnosis broadened to include cocaine withdrawal ,144.0
    serum creatine kinase 247 IU/L ,144.0
    received IV dantrolene 2.5 mg/kg ,144.0
    quetiapine discontinued ,144.0
    mirtazapine discontinued ,144.0
    haloperidol discontinued ,144.0
    dysautonomia resolved ,144.5
    rigidity resolved ,144.5
    hyperreflexia resolved ,144.5
    temperature downtrended ,144.5
    blood cultures sent ,144.0
    urine cultures sent ,144.0
    lower respiratory cultures sent ,144.0
    continued on maintenance oral dantrolene ,168.0
    resolution of rigidity ,168.0
    improvement in fever curve ,168.0
    bromocriptine added ,192.0
    dantrolene discontinued ,240.0
    rigidity recurred ,264.0
    hyperreflexia recurred ,264.0
    dantrolene restarted ,264.0
    tapered 14-day course ,264.0
    passed spontaneous breathing trial ,312.0
    extubated ,312.0
    mental status returned to baseline ,312.0
    no further recurrence of symptoms ,312.0
    resumed quetiapine 50 mg QHS ,528.0
    discharged ,696.0
    no shortness of breath ,0.0
    denies chest pain ,0.0
